EUVIMEDScopri EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Malignancy‐associated immune responses: Lessons from human inborn errors of immunity

Agnel Aliyath iD, Ayolola Eni-Olotu iD, Niamh Donaldson iD, Priyanka Trivedi iD

Immunology · 2023-11 · 170 (3) · 319-333

DOI: 10.1111/imm.13675 ↗

At a glance

Übersichtsarbeit in Immunology, published online on 2023-06-19. Written by Agnel Aliyath and 3 co-authors. Institution: Faculty of Medicine, Imperial College London, UK. Major MEDLINE topics: Neoplasms. Cited 6 times so far (Crossref); 143 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

It is widely understood that cancer is a significant cause of morbidity and mortality worldwide. Despite numerous available treatments, prognosis for many remains poor, thus, the development of novel therapies remains essential. Given the incredible success of many immunotherapies in this field, the important contribution of the immune system to the control, and elimination, of malignancy is clear. While many immunotherapies target higher‐order pathways, for example, through promoting T‐cell activation via immune checkpoint blockade, the potential to target specific immunological pathways is largely not well researched. Precisely understanding how immunity can be tailored to respond to specific challenges is an exciting idea with great potential, and may trigger the development of new therapies for cancer. Inborn Errors of Immunity (IEI) are a group of rare congenital disorders caused by gene mutations that result in immune dysregulation. This heterogeneous group, spanning widespread, multisystem immunopathology to specific immune cell defects, primarily manifest in immunodeficiency symptoms. Thus, these patients are particularly susceptible to life‐threatening infection, autoimmunity and malignancy, making IEI an especially complex group of diseases. While precise mechanisms of IEI‐induced malignancy have not yet been fully elucidated, analysis of these conditions can highlight the importance of particular genes, and downstream immune responses, in carcinogenesis and may help inform mechanisms which can be utilised in novel immunotherapies. In this review, we examine the links between IEIs and cancer, establishing potential connections between immune dysfunction and malignancy and suggesting roles for specific immunological mechanisms involved in preventing carcinogenesis, thus, guiding essential future research focused on cancer immunotherapy and providing valuable insight into the workings of the immune system in both health and disease.

Subjects

MeSH terms (MEDLINE)

NeoplasmsHumansCarcinogenesisImmunotherapyAutoimmunityLymphocyte Activation

Author keywords

immune systeminborn errors of immunitymalignancyprimary immunodeficiency

Authors and institutions

  • Faculty of Medicine, Imperial College London, UK.

ORCID profiles: Agnel Aliyath, Ayolola Eni-Olotu, Niamh Donaldson, Priyanka Trivedi

Cite

APA

Aliyath, A., Eni-Olotu, A., Donaldson, N., & Trivedi, P. (2023). Malignancy‐associated immune responses: Lessons from human inborn errors of immunity. Immunology, 170(3), 319-333. https://doi.org/10.1111/imm.13675

Vancouver

Aliyath A, Eni-Olotu A, Donaldson N, Trivedi P. Malignancy‐associated immune responses: Lessons from human inborn errors of immunity. Immunology. 2023;170(3):319-333. doi:10.1111/imm.13675

BibTeX
@article{Aliyath2023,
  author = {Aliyath, Agnel and Eni-Olotu, Ayolola and Donaldson, Niamh and Trivedi, Priyanka},
  title = {Malignancy‐associated immune responses: Lessons from human inborn errors of immunity},
  journal = {Immunology},
  year = {2023},
  volume = {170},
  number = {3},
  pages = {319--333},
  doi = {10.1111/imm.13675}
}
Start for free →